이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Sonic Healthcare 미래 성장

Future 기준 확인 1/6

Sonic Healthcare (는) 각각 연간 12.2% 및 5.3% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 11.6% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 8.9% 로 예상됩니다.

주요 정보

12.2%

수익 성장률

11.6%

EPS 성장률

Healthcare 수익 성장	19.3%
매출 성장률	5.3%
향후 자기자본 수익률	8.9%
애널리스트 커버리지	Good
마지막 업데이트	29 Jun 2024

최근 미래 성장 업데이트

Recent updates

수익 및 매출 성장 예측

CHIA:SHL - 애널리스트의 미래 추정치 및 과거 재무 데이터 (AUD Millions )
날짜	수익	수익	잉여 현금 흐름	작전 현금	평균 애널리스트 수
6/30/2026	9,757	651	940	1,437	14
6/30/2025	9,368	561	846	1,366	15
6/30/2024	8,840	493	695	1,180	15
12/31/2023	8,392	505	571	1,138	N/A
9/30/2023	8,281	595	772	1,304	N/A
6/30/2023	8,169	685	974	1,471	N/A
3/31/2023	8,417	850	1,260	1,721	N/A
12/31/2022	8,666	1,015	1,545	1,970	N/A
9/30/2022	9,003	1,238	1,696	2,098	N/A
6/30/2022	9,340	1,461	1,847	2,226	N/A
3/31/2022	9,209	1,463	1,885	2,249	N/A
12/31/2021	9,078	1,465	1,922	2,273	N/A
9/30/2021	8,916	1,390	1,801	2,158	N/A
6/30/2021	8,754	1,315	1,680	2,043	N/A
3/31/2021	8,339	1,133	1,492	1,840	N/A
12/31/2020	7,923	951	1,304	1,637	N/A
9/30/2020	7,378	739	1,170	1,498	N/A
6/30/2020	6,832	528	1,036	1,360	N/A
3/31/2020	6,703	554	827	1,187	N/A
12/31/2019	6,573	581	618	1,013	N/A
9/30/2019	6,353	565	540	930	N/A
6/30/2019	6,134	550	461	847	N/A
3/31/2019	5,952	510	452	816	N/A
12/31/2018	5,770	470	443	784	N/A
9/30/2018	5,655	473	442	776	N/A
6/30/2018	5,541	476	440	768	N/A
3/31/2018	5,430	468	429	762	N/A
12/31/2017	5,319	460	417	755	N/A
9/30/2017	5,220	444	N/A	746	N/A
6/30/2017	5,122	428	N/A	736	N/A
3/31/2017	5,081	444	N/A	726	N/A
12/31/2016	5,040	460	N/A	716	N/A
9/30/2016	5,029	456	N/A	712	N/A
6/30/2016	5,018	451	N/A	708	N/A
3/31/2016	4,829	406	N/A	647	N/A
12/31/2015	4,639	362	N/A	585	N/A
9/30/2015	4,420	355	N/A	549	N/A
6/30/2015	4,201	348	N/A	512	N/A
3/31/2015	4,115	365	N/A	540	N/A
12/31/2014	4,029	382	N/A	568	N/A
9/30/2014	3,971	383	N/A	562	N/A
6/30/2014	3,913	385	N/A	556	N/A
3/31/2014	3,799	373	N/A	517	N/A
12/31/2013	3,685	362	N/A	477	N/A
9/30/2013	3,585	348	N/A	468	N/A
6/30/2013	3,484	335	N/A	459	N/A

애널리스트 미래 성장 예측

수입 대 저축률: SHL 의 연간 예상 수익 증가율( 12.2% )이 saving rate( 2.3% 보다 높습니다. ).

수익 vs 시장: SHL 의 연간 수익( 12.2% ) Australian 시장( 13.8% 보다 느리게 성장할 것으로 예상됩니다. 13.8% 연간).

고성장 수익: SHL 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.

수익 대 시장: SHL 의 수익(연간 5.3% ) Australian 시장( 5.5% 보다 느리게 성장할 것으로 예상됩니다. 5.5% 연간).

고성장 수익: SHL 의 수익(연간 5.3% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: SHL 의 자본 수익률은 3년 내에 최저 수준이 될 것으로 예상됩니다( 8.9 %).

Sonic Healthcare 미래 성장

Future 기준 확인 1/6

주요 정보

최근 미래 성장 업데이트

Sonic Healthcare Limited Do Not Provide Earnings Guidance for the Fiscal Year 2021 Due to COVID-19

Recent updates

Sonic in the Running for Healius Imaging Business

New minor risk - Shareholder dilution

Upcoming dividend of AU$0.43 per share

First half dividend increased to AU$0.43

First half 2024 earnings released: EPS: AU$0.43 (vs AU$0.81 in 1H 2023)

Sonic Healthcare Limited to Report First Half, 2024 Results on Mar 20, 2024

Sonic Healthcare Limited (ASX:SHL) signed binding agreements to acquire Pathology Watch Inc. for $130 million.

Finance Director recently sold AU$1.3m worth of stock

Upcoming dividend of AU$0.62 per share at 3.2% yield

Sonic Healthcare Limited Announces Dividend for the Six Months Ended June 30, 2023, Payable on 21 September, 2023

Full year 2023 earnings released: EPS: AU$1.46 (vs AU$3.06 in FY 2022)

Sonic Healthcare Limited to Report Fiscal Year 2023 Results on Aug 17, 2023

Now 20% undervalued after recent price drop

Sonic Healthcare Limited (ASX:SHL) signed an binding agreement to acquire synlab Suisse SA from SYNLAB International GmbH for CHF 150 million.

Upcoming dividend of AU$0.42 per share at 3.1% yield

First half 2023 earnings released

Sonic Healthcare Limited Announces Dividend for the Six Months Ended December 31, 2022, Payable on March 22, 2023

Sonic Healthcare Limited to Report First Half, 2023 Results on Feb 16, 2023

CEO, MD & Executive Director recently sold AU$9.9m worth of stock

Sonic Healthcare Limited Announces Board Changes

Sonic Healthcare Limited, Annual General Meeting, Nov 17, 2022

Sonic Healthcare Limited, Annual General Meeting, Nov 27, 2022

Upcoming dividend of AU$0.60 per share

Full year 2022 earnings released: EPS: AU$3.06 (vs AU$2.76 in FY 2021)

Sonic Healthcare Limited Announces Dividend for the Six Months Ended June 30, 2022, Payable on 21 September, 2022

Insufficient new directors

Upcoming dividend of AU$0.40 per share

Sonic Healthcare Limited (ASX:SHL) announces an Equity Buyback for AUD 500 million worth of its shares.

First half 2022 earnings: EPS in line with expectations, revenues disappoint

Sonic Healthcare Limited Announces Dividend for the Six Months Ended December 31, 2021, Payable on March 23, 2022

Sonic Healthcare Limited (ASX:SHL) acquired ProPath Laboratory, Inc.

Full year 2021 earnings released: EPS AU$2.76 (vs AU$1.11 in FY 2020)

CEO, MD & Executive Director recently sold AU$8.4m worth of stock

Upcoming dividend of AU$0.55 per share

Full year 2021 earnings released: EPS AU$2.76 (vs AU$1.11 in FY 2020)

Sonic Healthcare Limited (ASX:SHL) signed a binding agreement to acquire Canberra Imaging Group.

Rhythm Biosciences Adds Sonic Clinical Services to Colostat Clinical Trial

New 90-day low: AU$31.39

First half 2021 earnings released: EPS AU$1.42 (vs AU$0.54 in 1H 2020)

Revenue beats expectations

Sonic Healthcare Limited to Report First Half, 2021 Results on Feb 18, 2021

Sonic Healthcare Limited to Report Fiscal Year 2021 Results on Aug 18, 2021

Sonic Healthcare Limited Elects Professor Suzanne Crowe as A Director

Sonic Healthcare Limited Do Not Provide Earnings Guidance for the Fiscal Year 2021 Due to COVID-19

Earnings released

New 90-day high - AU$34.66

Sonic Healthcare Limited to Report Fiscal Year 2020 Results on Aug 20, 2020

New 90-day high - AU$33.38

New 90-day high - AU$31.60

수익 및 매출 성장 예측

애널리스트 미래 성장 예측

주당 순이익 성장 예측

미래 자기자본 수익률

성장 기업 발견